Life Science Logistics expands its Indianapolis facility
More CII and refrigerated storage
Life Science Logistics (Dallas) has opened a 2,350-sq.ft vault (pictured) for CII (Class II controlled substances) and also a 2,700-sq.ft. space for refrigerated (2-8°C) storage at its existing Indianapolis facility. That location now have just under 400,000 sq.ft of capacity.
“We’re seeing increased demand for refrigerated space from our pharmaceutical and biotech clients,” said Richard Beeny, CEO, adding that LSL chose to expand at its Indianapolis location because of Indiana’s geographic reach and the city’s tax advantages for its clients. The CII expansion was driven, in part, by the reclassification, last year, of CIII hydrocodone to CII.
Life Science Logistics has four US locations (Dallas, Indianapolis, Baltimore and Atlanta, totaling 1.35 million sq. ft of capacity exclusively for life sciences products. In addition to the storage, it offers 3PL logistics services, including distribution, order to case and regulatory compliance.
Protecting Temperature-Sensitive Pharmaceuticals, Without Unnecessary Plastic Waste
March 24th 2025Advances in the life sciences are driving a significant increase in the number of temperature-sensitive pharmaceuticals. The packaging industry is meeting the moment with advances of its own, including high-performance, environmentally-friendly materials that allow life science companies meet stringent thermal requirements and ambitious CO2e reduction goals. In this episode, TemperPack’s CEO Peter Wells shares insights from working with life sciences to move to certified biobased, home compostable, and curbside recyclable shipping solutions.
